HIV/STI/PrEP

Dr. Atkinson is a biostatistician providing project-based and ad hoc consultancy in the division. His methodological research includes developing methods for handling missing data in clinical trials and for observational data, novel clinical trial design methods, trial emulation and Bayesian modelling.

Dr. Barrette specializes in the primary care of patients living with HIV infection and AIDS and has a special interest in opioid use disorder.

Dr. Curtis specializes in clinical infectious diseases, with a particular focus on diseases impacting pregnant people living with substance use disorders, such as HIV, hepatitis C, and syphilis.

Dr. Fabricant attends on the inpatient ID consult service at BJH. He runs a general clinic and also works with our HCV and STI programs.

Using the lens of implementation science, Dr. Geng conducts research to advance the use of evidence-based interventions in the public health response to HIV and non-communicable diseases.

Dr. Grant specializes in the innate immune responses to the pathogens causing Tuberculosis (TB), Nontuberculous Mycobacterial (NTM) and COVID-19 infections, and his laboratory research includes the search for novel therapies targeting the host for these difficult infections.

Dr. Hong is a core faculty member of the ID Fellowship Training Program, serving as Co-Director of the STI and HIV Track. He specializes in HIV and STI care, HIV prevention, and public health, with a special focus on outpatient HIV care, HIV PrEP implementation, inpatient outcomes for syphilis treatment, and community education regarding STI diagnosis and treatment.

Dr. Kyei specializes in HIV basic and translational research, with a special focus on viral latency and reactivation specifically:  (i) characterization of factors that control HIV replication in macrophages, dendritic and resting T cells and (ii) identification of cellular factors and small molecules required for HIV reactivation in latently infected cell and (iii) perspectives of HIV patients on HIV cure.

Dr. López is a public health researcher who uses her clinical practice skills to further advance the field of sexual health using public health and social work theories and frameworks.

Dr. Marks is a core faculty member of the ID Fellowship Training Program, serving as Director of Fellow Basic/Translational research, infectious diseases and substance use. She specializes in clinical infectious diseases with a special focus on infectious complications in people who inject drugs, such as infective endocarditis and Hepatitis B & C virus infections. Other core research interests include infections in pregnant women.

Dr. McCrary specializes in clinical infectious diseases and addiction medicine with a special focus on the infectious complications of substance use, such as Hepatitis C and Serratia endocarditis, and related quality improvement initiatives.

Dr. Mody's overarching research interests are in utilizing implementation science and epidemiologic methods to better understand how to deliver high-quality and patient-centered HIV care in routine practice resource-limited settings.

Dr. Mondy's current areas of interest include academic inpatient infectious diseases and antibiotic stewardship, as well as care of underserved HIV populations through innovative telemedicine services.

Areas of Interest in ID:
Host pathogen interaction in bacterial pathogenesis

Dr. Priya Pal is a physician-scientist and infectious disease specialist whose research bridges fundamental immunology and translational HIV science. She additionally runs an HIV cure trial out of the Infectious Diseases Clinical Research Unit (ID-CRU) and serves on the inpatient infectious diseases consult service.

Dr. Parra-Rodriguez specializes in the longitudinal clinical care of people with HIV, with a special clinical research focus on aging, age-related clinical conditions, and mental health in people with HIV. As a core faculty member of the ID Fellowship Program, he serves as Co-Director of the STI and HIV Track.

Marilia Pinzone is an infectious diseases physician-scientist. As a scientist, she is currently investigating chronic inflammation during antiretroviral therapy (ART). As a physician, Dr. Pinzone's interests are outpatient care of people living with HIV, infectious diseases, and metabolic complications of HIV.

Dr. Powderly has been actively involved in HIV-related clinical research for over thirty years with specific interests in opportunistic infections, metabolic complications and long-term outcomes of antiretroviral therapy.

Dr. Presti specializes in clinical and translational research in infectious disease, with a special focus on HIV, SARS-CoV-2 and other viral infections.